Skip to Main Content

4,087

Views

14

CrossRef citations to date

0

Altmetric

Report

Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis

Susanne Klinta Affibody AB, Solna, SwedenView further author information

,

Joachim Feldwischa Affibody AB, Solna, SwedenView further author information

,

Lindvi Gudmundsdottera Affibody AB, Solna, SwedenView further author information

,

Karin Dillner Bergstedta Affibody AB, Solna, SwedenView further author information

,

Elin Gunneriussona Affibody AB, Solna, SwedenView further author information

,

Ingmarie Höidén Guthenberga Affibody AB, Solna, SwedenView further author information

,

Anders Wennborga Affibody AB, Solna, SwedenView further author information

,

Andrew C. Nyborgb ACELYRIN, Agoura Hills, CA, USAView further author information

,

Amol P. Kambojb ACELYRIN, Agoura Hills, CA, USAView further author information

,

Paul M. Pelosob ACELYRIN, Agoura Hills, CA, USAView further author information

,

David Bejkera Affibody AB, Solna, SwedenView further author information

&

Fredrik Y. Frejda Affibody AB, Solna, Sweden;c Department of Immunology, Genetics and Pathology, IGP, Uppsala University, Uppsala, SwedenCorrespondence[email protected]
View further author information